ClinicalTrials.gg
CompletedNCT02366585Updated Apr 7, 2017

The Effect of Locally Delivered Ciclosporin as an Adjunct to Healing After Treatment of Periodontal Pockets

A Phase 2 interventional study of Ciclosporin in Periodontitis, sponsored by PerioC Limited. Completed at 1 site in Sweden. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2017-04-07.

Sponsored by PerioC Limited · Phase 2, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
23
Allocation
Not applicable
Ages
30 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 10 studies in Periodontitis with a site in Sweden — 5 open to participants now, 6 under way, none of them phase 3. Periodontitis · Sweden.

Started
2015
the only one that year
Phase 2
Only one
of the 10
Registered
2nd of 10
by date
Lead sponsor
1 of 10
PerioC Limited

Among the 10 studies in Periodontitis with a site in Sweden, this one is the only one that started in 2015, is the only one in phase 2, and was the 2nd registered.

Periodontitis

1,235 studies on the registry are indexed under Periodontitis; 298 are open to participants now.

Browse Periodontitis studies →

Open to participants now

5 of the 10 studies in Periodontitis with a site in Sweden are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 160 Periodontitis studies recruiting now, 79 (49%) set no upper age limit and 60 (38%) stop at 75 or younger; 12 take children under 18; 77 take healthy volunteers.

This study: 30 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Periodontitis with a site in Sweden, or all of them as a file.
02

Study summary

The main purpose of the trial is to investigate the effect of locally delivered ciclosporin as an adjunct to non-surgical mechanical debridement in the treatment of chronic periodontitis and to compare it to mechanical debridement alone.

03

Conditions studied

  • Periodontitis

Browse trials for

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients in good general health
  • 2 pairs of contralateral interproximal periodontal sites with probing depths of ≥7mm in single-rooted teeth not associated with furcations or root furrows.The test sites should have a distance of at least two teeth to the control sites.
  • Teeth selected should have a vital pulp as determined by thermal or electric stimulation

Exclusion criteria

Exclusion Criteria:

  • Patients already included in other clinical trials involving therapeutic intervention (either medical or dental)
  • Periodontal treatment during the last 6 months
  • Antibiotic treatment 6 months prior to the start of the trial
  • Antibiotic prophylaxis required for dental treatment
  • Patients with acute infectious lesions in the areas of intended treatment
  • Regular anti-inflammatory medication
  • Known history of ciclosporin allergy
  • Ongoing medication that may affect the clinical features of periodontitis
  • Patients who are smokers
  • Patients that are immuno-compromized or on medication
  • Patients who are pregnant or lactating
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    Treatment with Ciclosporin

    Treatment of two periodontal pockets with ciclosporin gel Non-treatment of two periodontal pockets in same patient as comparator

    Drug: Ciclosporin

Interventions

  • Ciclosporin gel applied to two periodontal pockets

06

What researchers measure

Primary outcomes

  1. Probing pocket depth (PPD)

    Mean change in probing pocket depth (PPD) from baseline to 3-month examination

    Time frame: 3 months

  2. Bleeding on Probing (BoP)

    Change in BoP (measured as present or absent) from baseline to 3-month examination

    Time frame: 3 months

07

Study locations

1 site
  • The Sahlgrenska Academy, University of Gothenburg
    Gothenburg, 40530, Sweden
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2015, a primary completion of Sep 2016 and a completion of Oct 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 12, 2015
First posted
Feb 19, 2015
Start
Mar 2015
Primary completionActual
Sep 2016
CompletionActual
Oct 2016
Last update
Apr 7, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 7, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02366585
Lead sponsor
PerioC Limited
Responsible party
Sponsor
First posted
Feb 19, 2015
Start date
Mar 2015
Primary completion
Sep 2016
Completion
Oct 2016
Last update
Apr 7, 2017

Study contacts

Per Ramberg, PhD
principal investigator · Göteborg University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Cyclosporine

Start the discussion